Search
for
Sort by
Research 121–150 of 1000+
- Methylmalonic Acidemia: Can Treatment be Improved?
- Systemic Lupus Erythematosus—Vasculopathy/Vasculitis, Susac Syndrome, and Myasthenia Gravis
- Health hazard evaluation report: HETA-2000-0176-2829, The Centre for Well-Being at The Phoenician Resort, Scottsdale, Arizona.
- Cutaneous lupus erythematosus: a review
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Fox-Fordyce Disease
- Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction
- Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from a Web-Based Study from India.
- STUDY OF CLINICAL SPECTRUM OF GERIATRIC DERMATOSES IN PATIENTS ATTENDING A MULTI-SPECIALTY HOSPITAL
- Lupus Eritematosus Sistemik pada Pria
- Urticariform plaques: delayed hypersensitivity reaction type IV to enoxaparin
- D ERMATOLOGICAL MANIFESTATIONS - ARE THEY SPECIFIC MARKERS FOR SYSTEMIC INVOLVEMENT IN SLE ?
- Dermatoses of Pregnancy
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- A study of cutaneous manifestations in systemic lupus erythematosus
- A study of cutaneous manifestations of systemic lupus erythematosus in Malwa region of India
- TOPICAL STEROIDS
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Cutaneous toxicities of new treatments for melanoma
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19
- Multibacillary leprosy with positive serology misdiagnosed as systemic lupus erythematosus
- Cutaneous Manifestations of COVID-19: A Brief Review of a Possible Diagnostic Tool